brexucabtagene autoleucel
gilead
['brexu-cel']
congress #eha2023 | monia marchetti discusses the cost effectiveness of brexu-cel vs soc for the treatment of r/r all, showing that brexu-cel may represent a more cost effective treatment approach for this patient population. #allsm #medicalcongress #cancertherapy 
A global education platform providing clinical updates on acute lymphoblastic leukemia. #leusm #allsm